Want to buy for someone else? You can purchase a token at check out.
Overview
Hypercoagulability disorder is a highly prevalent clinical condition characterized by abnormal blood coagulation, which leads to thrombosis inside the blood vessels. The most common clinical manifestations are deep vein thrombosis (DVT) and pulmonary embolism (PE); both are types of venous thromboembolism (VTE). DVT may result from the formation of blood clots in the peripheral vascular bed. PE is a life-threatening condition caused by blockage in major pulmonary vessels that rapidly progresses to cardiogenic shock, circulatory failure, and death. VTE can also occur in other sites, including the veins in the brain, kidneys, liver, mesenteric circulation, arms, and legs. The challenge in managing hypercoagulability disorders is due to the clinical variability of the disease etiology and numerous possible sites of blockage balanced against treatment objectives, outcomes, and cost.
Goals and Learning Outcomes
- Identify risk factors and symptoms associated with hypercoagulability disorders, including deep vein thrombosis and pulmonary embolism
- Describe the tests and tools available to assess the risk of developing a blood clot
- Review how evidence-based guidelines for the prevention and treatment of VTE can be used by the healthcare team
- Analyze treatment modalities and identify goals of therapy in the management of VTE and how various members of the healthcare team can contribute to the care process
- Review key patient education points that the healthcare team should emphasize regarding the symptoms of thrombosis, outcomes of pharmacotherapy, lifestyle interventions, etc.
- Discuss challenges encountered with patient adherence to anticoagulant therapy
Course Details
Course Originally Released on : 8/7/2019
60288
Course Author
PhD, RPh
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.